Panda et al., 2013 - Google Patents
Design and evaluation of zidovudine loaded natural biodegradable microcapsules employing colophony resin as microencapsulating agentPanda et al., 2013
View PDF- Document ID
- 7085432226361534874
- Author
- Panda S
- Pattnaik S
- Maharana L
- Botta G
- Mahapatra A
- Publication year
- Publication venue
- Int. J. Phar. Pharm. Sci
External Links
Snippet
The aim of the present study is to develop and evaluate natural biodegradable microcapsules of zidovudine (AZT) by using colophony resin as microencapsulating agent, which after oral administration could improve the bioavailability of the drug, in order to …
- 239000003094 microcapsule 0 title abstract description 74
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Basu et al. | Preparation and characterization of nitrendipine-loaded Eudragit RL 100 microspheres prepared by an emulsion-solvent evaporation method | |
DK159716B (en) | INHALATION POWDER, PROCEDURE FOR PREPARING IT AND PHARMACEUTICAL FORMULA CONTAINING SUCH | |
UA110773C2 (en) | Method of producing powder containing nano- and microparticles | |
DE3024858A1 (en) | CONTINUOUSLY RELEASING PHARMACEUTICAL PREPARATION OF A SOLID MEDICINAL MATERIAL | |
Abdallah et al. | Development and characterization of controlled release ketoprofen microspheres | |
US20180338927A1 (en) | Ether cellulose derivative microparticle | |
Pohlen et al. | Preparation, physicochemical characterisation and DoE optimisation of a spray-dried dry emulsion platform for delivery of a poorly soluble drug, simvastatin | |
Mali et al. | Microencapsulation: A review | |
Letchmanan et al. | Application of transglycosylated stevia and hesperidin as drug carriers to enhance biopharmaceutical properties of poorly-soluble artemisinin | |
ES2584403T3 (en) | Process for the preparation of enteric alginate microcapsules by ionic gelation containing diclofenac or one of its salts and multiparticulate pharmaceutical composition containing them | |
Panda et al. | Design and evaluation of zidovudine loaded natural biodegradable microcapsules employing colophony resin as microencapsulating agent | |
EP1469835B1 (en) | Stable salts of o-acetylsalicylic acid containing basic amino acids ii | |
RU2351352C2 (en) | Solid nanocomposition for delivery of biologically active substances | |
CN106999429A (en) | Nanoparticle suspension agent formulation | |
Abbaspour et al. | Preparation and Evaluation of Berberine-Excipient Complexes in Enhancing the Dissolution Rate of Berberine Incorporated into Pellet Formulations | |
Karthika et al. | Formulation development and In vitro characterization of solid self nano emulsifying drug delivery system for curcumin to target colon adenocarcinoma | |
Patel et al. | Formulation and evaluation of metformin hydrochloride microparticles by emulsion solvent evaporation technique | |
Patil et al. | Development and evaluation of sustain release simvastatin pellets | |
Bal et al. | Preparation and evaluation of mucoadhesive simvastatin microcapsules using orifice gelation technique | |
Panda et al. | Fabrication of Zidovudine Loaded Olibanum Resin Microcapsules: Employing Natural Resin as Controlled Release Coat Material | |
Thorat et al. | Fast dissolving drug delivery system of cilnidipine using gelucire 50/13 | |
Priya | Self-emulsifying systems of Aceclofenac by extrusion/Spheronization: Formulation and evaluation | |
CN1822818B (en) | Particles containing an acitve agent in the form of a co-precipitate | |
Panda et al. | Formulation And In-Vitro Characterization Of Lamivudine Embedded Natural Resin Microspheres Using Olibanum As Drug Carriers | |
Patil et al. | Utilization of Natural Olibanum Gum Resin as a Rate Controlling Polymer in Design and Evaluation of Microspheres of an Antiretroviral Drug by using a Unique Spray Drying Technique |